QUESTIONSClinical Trials in Oncology December 1-2 2009 (CTO1209)
Venue: TBD
| Event Date/Time: Dec 01, 2009 | End Date/Time: Dec 02, 2009 |
| Registration Date: Aug 18, 2009 | |
| Early Registration Date: Aug 18, 2009 |
Report as SpamDescription
Oncology is now the fastest growing area within the pharma industry. The drug’s market is expected to surpass US$ 78 billion by 2012 and the market for cancer biotherapy treatment is predicted to reach US$ 60 billion in the next 10 years.
With a lot of opportunity to be had in this rapidly evolving field, the pressure is on for big pharma and biotech companies to discover innovative and effective therapies and launch them as quickly as possible. However, a number of challenges in this area remain specifically with regards to patient recruitment, operational issues related to global studies, new approaches to targeted therapies and balancing safety and efficacy targets.
VIBpharma’s 2nd annual Clinical Trials in Oncology event being held on 1 and 2 December in Munich aims to establish solutions to both developmental and organisational issues. Key topics to be covered include:
Increasing enrolment by adopting innovative cancer patient recruitment strategies and managing sites effectively to achieve time and cost savings
Selecting the most appropriate sites in emerging markets that provide the right resources for your oncology trials
Identifying diagnostic testing methods and methodologies to evaluate the results of your oncology trial effectively
Understanding issues regarding targeted cancer therapies in order to move towards personalised therapies
Through case study driven presentations from leading pharma and biotech companies and a series of interactive roundtable discussions, this event will provide best practice solutions to help you comply with existing and upcoming challenges in the market.
With a lot of opportunity to be had in this rapidly evolving field, the pressure is on for big pharma and biotech companies to discover innovative and effective therapies and launch them as quickly as possible. However, a number of challenges in this area remain specifically with regards to patient recruitment, operational issues related to global studies, new approaches to targeted therapies and balancing safety and efficacy targets.
VIBpharma’s 2nd annual Clinical Trials in Oncology event being held on 1 and 2 December in Munich aims to establish solutions to both developmental and organisational issues. Key topics to be covered include:
Increasing enrolment by adopting innovative cancer patient recruitment strategies and managing sites effectively to achieve time and cost savings
Selecting the most appropriate sites in emerging markets that provide the right resources for your oncology trials
Identifying diagnostic testing methods and methodologies to evaluate the results of your oncology trial effectively
Understanding issues regarding targeted cancer therapies in order to move towards personalised therapies
Through case study driven presentations from leading pharma and biotech companies and a series of interactive roundtable discussions, this event will provide best practice solutions to help you comply with existing and upcoming challenges in the market.
